Skip to content

Clinical trials

Recruiting Observational Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Observational Status: Recruiting Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20091
20111
20122
20131
20141
20151
20171
20202
20212
20221
20231
20244
202516
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical University of Vienna3
Nantes University Hospital2
National Eye Institute (NEI)2
AI-Spectral1
Astellas Pharma Global Development, Inc.1
Ataturk University1
Center for Eye Research Australia1
Centre Hospitalier Universitaire, Amiens1
Complement Therapeutics1
Data Yakka, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration39
Geographic Atrophy7
Diabetic Retinopathy5
Retinal Diseases4
Retinitis Pigmentosa4
Diabetes Mellitus3
Retinal Degeneration3
Alzheimer Disease2
Amyotrophic Lateral Sclerosis2
Anxiety Disorders2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.